US Patent Issued to Medtronic on July 7 for "Determining an efficacy of a treatment program" (Minnesota Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,672,821, issued on July 7, was assigned to Medtronic Inc. (Minneapolis).

"Determining an efficacy of a treatment program" was invented by Ekaterina B. Morgounova (Shoreview, Minn.), Shantanu Sarkar (Roseville, Minn.), Eduardo N. Warman (Maple Grove, Minn.) and Joel R. Lauer (Clearwater, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure is directed to devices, systems, and techniques for determining an efficacy of a treatment program. For example, a medical device system includes a medical device including one or more sensors configured to generate a signal that indicates a parameter of a patient. Additionally, the medical device system...